Document Type : Original Research

Authors

1 Department of Pathology, School of Medicine Shiraz University of Medical Sciences, Shiraz, Iran

2 Gastroenterohepatology Research Center, Namazi Hospital, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

3 Clinical Education Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

10.30699/ijp.2022.541736.2812

Abstract

Background & Objective: The TSH reference range's validity affects the thyroid dysfunction diagnosis. The primary objective of this study is to determine the reference range, which is established according to age and region.
Methods: The data were collected retrospectively from people over the age of one who visited Motahari Clinic for routine health checkups between August 2017 and October 2019. TSH, T4, T3, personal drug usage, and thyroid history were collected. After excluding subjects with thyroid diseases and outliers, a list of 1392 participants was analyzed. Hormone intervals of men and women ≥1 year old have been determined using the non-parametric method.
Results: The non-disease subjects' TSH, T3, and T4 reference ranges were 0.64 to 5.94 lU/mL, 0.91 to 2.47 ng/dL, and 5.53 to 12.48 g/dL, respectively. According to this range, total thyroid dysfunction prevalence in our study in children was 8.94%. There was no significant difference between TSH, T4 level, and sex in the non-disease population (P=0.46 and 0.13, respectively), but there was a statistical difference between sex and T3 (P =0.03). Our study also illustrates that for subjects under 18 years old and above it, hormones (TSH, T3, T4) concentration is statistically different (P≤0.001).
Conclusion: We found a statistical difference between hormone values after and before age 18 (P=≤0.01); therefore, it is not appropriate to use the same reference range for children under age 18 and adults. There was male dominance in the population 1-18 years old. 

Keywords

Main Subjects

  1. Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355-82. [PMID] [PMCID] [DOI:10.1152/physrev.00030.2013]
  2. Torremante P, Flock F, Kirschner W. Free thyroxine level in the high normal reference range prescribed for nonpregnant women may reduce the preterm delivery rate in multiparous. J Thyroid Res. 2011;2011:905734. [DOI:10.4061/2011/905734] [PMID] [PMCID]
  3. de Escobar GM, Obregon MJ, del Rey FE. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metabol. 2004;18(2):225-48. [DOI:10.1016/j.beem.2004.03.012] [PMID]
  4. Wang Y, Zhang Yx, Zhou Yl, Xia J. Establishment of reference intervals for serum thyroid‐stimulating hormone, free and total thyroxine, and free and total triiodothyronine for the Beckman Coulter DxI‐800 analyzers by indirect method using data obtained from Chinese population in Zhejiang Province, China. J Clin Lab Anal. 2017;31(4):e22069. [DOI:10.1002/jcla.22069] [PMID] [PMCID]
  5. Cooper DS. Subclinical hypothyroidism. Jama. 1987;258(2):246-7. [PMID] [DOI:10.1001/jama.1987.03400020088037]
  6. Canaris GJ, Tape TG, Wigton RS. Thyroid disease awareness is associated with high rates of identifying subjects with previously undiagnosed thyroid dysfunction. BMC Public Health. 2013;13(1):1-7. [DOI:10.1186/1471-2458-13-351] [PMID] [PMCID]
  7. Sikaris KA. Physiology and its importance for reference intervals. Clin Biochem Rev. 2014;35(1):3-14.
  8. Laboratory C, Institute S. "How to Define and Determine Reference Intervals in the Clinical Laboratory; Approved Guideline-Second Edition" CLSI document C28-A2. 2000.
  9. Park SY, Kim HI, Oh H-K, Kim TH, Jang HW, Chung JH, et al. Age-and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: data from Korean National Health and Nutrition Examination Survey IV (2013-2015). PLoS One. 2018;13(2). [DOI:10.1371/journal.pone.0190738] [PMID] [PMCID]
  10. Sheehan MT. Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed - A Review for Primary Care. Clin Med Res. 2016;14(2):83-92. [DOI:10.3121/cmr.2016.1309] [PMID] [PMCID]
  11. Aminorroaya A, Janghorbani M, Amini M, Hovsepian S, Tabatabaei A, Fallah Z. The prevalence of thyroid dysfunction in an iodine-sufficient area in Iran. Arch Iran Med. 2009;12(3):262-70.
  12. Hoseini M, Hekmatnia A, Hashemipour M, Basiratnia R, Omidifar N, Rezazade A, et al. Sonographic assessment of congenitally hypothyroid children in Iran. Endokrynol Polska. 2010;61(6):665-70.
  13. Moslem TS, Seyyed Mohammad T, Hamid Reza S, Hosein F, Azimeh G. Trend of Congenital Hypothyroidism Incidence and Its Affecting Factors in Shahr-e-Kord, Western Iran. Iran J Public Health. 2020;49(5).
  14. Franklyn J, Shephard M. Evaluation of Thyroid Function in Health and Disease. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, et al., editors. Endotext. South Dartmouth (MA): MDText. com, Inc.; 2000.
  15. Sheikhbahaei S, Mahdaviani B, Abdollahi A, Nayeri F. Serum thyroid stimulating hormone, total and free T4 during the neonatal period: Establishing regional reference intervals. Indian J Endocrinol Metabol. 2014;18(1):39-43. [DOI:10.4103/2230-8210.126528] [PMID] [PMCID]
  16. Aggarwal N, Razvi S. Thyroid and aging or the aging thyroid? An evidence-based analysis of the literature. J Thyroid Res. 2013;2013:481287. [DOI:10.1155/2013/481287] [PMID] [PMCID]
  17. Schnabl K, Chan MK, Gong Y, Adeli K. Closing the gaps in paediatric reference intervals: the CALIPER initiative. Clin Biochem Rev. 2008;29(3): 89-96.
  18. Bertholf RL. Statistical methods for establishing and validating reference intervals. Lab Med. 2006; 37(5):306-10. [DOI:10.1309/CBMHPRFNLU1XA4XV]
  19. Kim WG, Kim WB, Woo G, Kim H, Cho Y, Kim TY, et al. thyroid stimulating hormone reference range and prevalence of thyroid dysfunction in the Korean population: Korea National Health and Nutrition Examination Survey 2013 to 2015. Endocrinol Metabol. 2017;32(1):106-14. [DOI:10.3803/EnM.2017.32.1.106] [PMID] [PMCID]
  20. Stathatos N, Wartofsky L. Managing subclinical hypothyroidism in women. Womens Health Primary Care. 2002;5:239-46.
  21. Stephens P. The Endocrine Society: current issues in thyroid disease management. Endocr News. 2004;29:23-6.
  22. Guan H, Shan Z, Teng X, Li Y, Teng D, Jin Y, et al. Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes. Clin Endocrinol (Oxf). 2008;69(1):136-41. [DOI:10.1111/j.1365-2265.2007.03150.x] [PMID]
  23. Xing D, Liu D, Li R, Zhou Q, Xu J. Factors influencing the reference interval of thyroid-stimulating hormone in healthy adults: A systematic review and meta-analysis. Clin Endocrinol (Oxf). 2021;95(3):378-89. [DOI:10.1111/cen.14454] [PMID] [PMCID]
  24. Guidi GC, Salvagno GL. Reference intervals as a tool for total quality management. Biochem Med. 2010;20(2):165-72. [DOI:10.11613/BM.2010.020]
  25. Hubl W, Schmieder J, Gladrow E, Demant T. Reference intervals for thyroid hormones on the architect analyser. Clin Chem Lab Med. 2002;40 (2): 165-6. [DOI:10.1515/CCLM.2002.028] [PMID]
  26. Nelson JC, Clark SJ, Borut DL, Tomei RT, Carlton EI. Age-related changes in serum free thyroxine during childhood and adolescence. J Pediatr. 1993;123(6): 899-905. [DOI:10.1016/S0022-3476(05)80385-3]
  27. Kapelari K, Kirchlechner C, Hogler W, Schweitzer K, Virgolini I, Moncayo R. Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study. BMC Endocr Disord. 2008;8(1):15. [PMCID] [DOI:10.1186/1472-6823-8-15] [PMID]
  28. Hershman JM, Pekary AE, Berg L, Solomon DH, Sawin CT. Serum thyrotropin and thyroid hormone levels in elderly and middle-aged euthyroid persons. J Am Geriatr Soc. 1993;41(8):823-8. [DOI:10.1111/j.1532-5415.1993.tb06177.x] [PMID]
  29. Fraser CG. Age-related changes in laboratory test results. Clinical implications. Drugs Aging. 1993;3(3):246-57. [DOI:10.2165/00002512-199303030-00006] [PMID]
  30. Lakshminarayana Gopaliah R, Dr. Sheetal Lakshminarayana G, Mr. Nidhish PS, Mr. Pramod M. Thyroid dysfunction in children and adolescence: Experience of a tertiary care centre in Kerala. Int J Pediatr Res. 2016;3(1). [DOI:10.17511/ijpr.2016.i01.02]
  31. Sajjadi-Jazi SM, Sharifi F, Varmaghani M, Meybodi HA, Farzadfar F, Larijani B. Epidemiology of hyperthyroidism in Iran: a systematic review and meta-analysis. J Diabetes Metabol Disord. 2018;17 (2):345-55. [DOI:10.1007/s40200-018-0367-1] [PMID] [PMCID]
  32. Garmendia Madariaga A, Santos Palacios S, Guillen-Grima F, Galofre JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923-31. [DOI:10.1210/jc.2013-2409] [PMID]
  33. Ahmad N, Panthari M, Gupta A, Chandra P, Nafees S. Prevalence of hypothyroidism among patients of Meerut, Uttar Pradesh: A hospital based study. Int J Med Sci Public Health. 2013;2(3):539-42. [DOI:10.5455/ijmsph.2013.080320132]
  34. Niafar M, Aliasgharzadeh A, Bahrami A, Najafipur F, editors. Prevalence of thyroid dysfunction in the elderly women of Iran. 11th European Congress of Endocrinology; 2009: BioScientifica.